Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar 25;7(2):100459.
doi: 10.1016/j.infpip.2025.100459. eCollection 2025 Jun.

MRSA: the enduring foe

Siobhain Kelly  1   2 , Gemma Winzor  3 , Simon Ching Lam  4
Affiliations
Editorial

MRSA: the enduring foe

Siobhain Kelly et al. Infect Prev Pract. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

GW is the Editor in Chief of Infection Prevention in Practice. SK is a trainee editor for Infection Prevention in Practice. SCL is an Editor of Infection Prevention in Practice.

References

    1. Murray Christopher JL., Ikuta Kevin Shunji, Sharara Fablina, Swetschinski Lucien, Aguilar Gisela Robles, Gray Authia, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The lancet. 2022;399(10325):629–655. - PMC - PubMed
    1. Abebe Milkias, Alemkere Getachew, Ayele Gizachew. Methicillin and vancomycin-resistant Staphylococcus aureus and associated risk factors among patients with wound infection in East Wallaga Zone, Western Ethiopia. Infection Prevention in Practice. 2024 - PMC - PubMed
    1. Sagiraju M., Prasad R., Gopi A. Diabetes and MRSA Infections: A comparative analysis in an Indian tertiary healthcare setting. Infection Prevention in Practice. 2024;6(3) - PMC - PubMed
    1. Boucher H.W., Wilcox M., Talbot G.H., Puttagunta S., Das A.F., Dunne M.W. Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med. 2014;370(23):2169–2179. - PubMed
    1. Dennis L.S., Daniel H., Harry L., John L.H., Donald H.B., Barry H., Linezolid MRSA Study Group Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2002;34(11):1481–1490. - PubMed

Publication types

LinkOut - more resources